NASDAQ$PVLA
Palvella Therapeutics Inc · Q2 2023 earnings
Q2 2023 earnings ·
Headline financials
Revenue & EPS history
Palvella Therapeutics Inc · Revenue · Quarterly
$20.1M
Q2 2023+442.3%vs Q2 2022
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2023
-1.0%
Avg return
Earnings day
-0.6%
Avg return
5 days after
+3.1%
Avg return
30 days after
59%
16 / 27 earnings
Positive
+9.3%
Q1 2020
Best reaction
-20.4%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -12.9% | -3.8% | -16.6% | |
| Q3 2024 | -0.1% | -4.2% | -15.6% | |
| Q2 2024 | +2.1% | +2.9% | +1.6% | |
| Q1 2024 | +1.3% | -0.4% | -10.1% | |
| Q3 2023 | +4.2% | -5.8% | -33.3% | |
| Q2 2023 | +2.7% | +9.1% | +36.4% | |
| Q1 2023 | +1.2% | +1.8% | +7.1% | |
| Q3 2022 | +1.0% | -3.7% | -1.0% | |
| Q2 2022 | -5.5% | -12.1% | -21.4% | |
| Q1 2022 | -20.4% | -24.9% | -20.9% | |
| Q3 2021 | +0.4% | -9.9% | -30.2% | |
| Q2 2021 | +3.0% | +4.9% | +44.9% | |
| Q1 2021 | +2.1% | +2.7% | +84.6% | |
| Q3 2020 | +6.8% | +7.6% | +19.2% | |
| Q2 2020 | +3.3% | +13.0% | +4.4% | |
| Q1 2020 | +9.3% | -6.5% | +11.7% | |
| Q3 2019 | -14.4% | -2.0% | -12.4% | |
| Q2 2019 | -2.6% | -4.5% | -15.9% | |
| Q1 2019 | +3.8% | +21.6% | +29.2% | |
| Q3 2018 | -13.5% | -24.9% | -19.9% | |
| Q2 2018 | +2.3% | +4.9% | -0.6% | |
| Q1 2018 | -2.3% | +1.1% | +3.0% | |
| Q3 2017 | +3.8% | +3.0% | +17.1% | |
| Q2 2017 | -1.1% | +2.4% | +15.1% | |
| Q1 2017 | +0.5% | +6.6% | +10.3% | |
| Q3 2016 | -0.7% | +4.7% | +2.7% | |
| Q2 2016 | -1.2% | +0.6% | -6.4% | |
| Q1 2016 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro